Safety, immunogenicity, and clinical response of a survivin-based peptide vaccine in therapy-resistant advanced cancer: Results from a phase I/II trial

Abstract only

Saved in:

Bibliographic Details
Published in	Journal of clinical oncology Vol. 26; no. 15_suppl; p. 3046
Main Authors	Becker, J. C., Wobser, M., Hofmeister, V., Bauer, B., Broecker, E. B., thor Straten, P., Andersen, M. H.
Format	Journal Article
Language	English Japanese
Published	20.05.2008
Online Access	Get full text

Loading…